Showing results (1061-1070 of 3,886) with videos related to
Sort By:
Pageof 389
Cancer Biology & Therapy|July 25, 2003
An antibody against DR4 (TRAIL-R1) in combination with doxorubicin selectively kills malignant but not normal prostate cellsChristina Voelkel-JohnsonCancer Biology & Therapy|July 25, 2003
Analysis of anaphase figures in routine histologic sections distinguishes chromosomally unstable from chromosomally stable malignanciesElizabeth Montgomery, Robb E Wilentz, Pedram Argani, et al.Cancer Biology & Therapy|July 25, 2003
Blood markers for vasculogenesis increase with tumor progression in patients with breast carcinomaLouis K Sussman, Jan Nalinee Upalakalin, Mark J Roberts, et al.Cancer Biology & Therapy|November 9, 2019
RNA-Seq analysis of peripheral blood mononuclear cells reveals unique transcriptional signatures associated with radiotherapy response of nasopharyngeal carcinoma and prognosis of head and neck cancerGuohong Liu, Xiaojiao Zeng, Balu Wu, et al.Cancer Biology & Therapy|November 12, 2019
Botryllamide G is an ABCG2 inhibitor that improves lapatinib delivery in mouse brainJonathan D Strope, Cody J Peer, Tristan M Sissung, et al.Cancer Biology & Therapy|February 5, 2019
LOX and ACSL5 as potential relapse markers for pancreatic cancer patientsWeidong Ma, Ting Li, Si Wu, et al.Cancer Biology & Therapy|February 11, 2020
Doxycycline-induced exogenous Bmi-1 expression enhances tumor formation in a murine model of oral squamous cell carcinomaJocelin M Kalish, Xiao-Han Tang, Theresa Scognamiglio, et al.Cancer Biology & Therapy|January 22, 2020
Identification of a minimal region of loss on chromosome 6q27 associated with poor survival of high-risk neuroblastoma patientsMarzia Ognibene, Martina Morini, Alberto Garaventa, et al.Cancer Biology & Therapy|January 22, 2020
Identification of a new cryptic PML-RARα fusion gene without t(15;17) and biallelic CEBPA mutation in a case of acute promyelocytic leukemia: a case detected only by RT-PCR but not cytogenetics and FISHZhanglin Zhang, Yawen Xu, Mei Jiang, et al.Cancer Biology & Therapy|December 19, 2019
Renal angiomyolipoma (AML) harboring a missense mutation of TSC2 with copy-neutral loss of heterozygosity (CN-LOH)Masashi Idogawa, Tokimasa Hida, Toshiaki Tanaka, et al.Pageof 389